These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33229426)

  • 1. Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches.
    Sebastián-Pérez V; Sifaoui I; Reyes-Batlle M; Domínguez-De Barros A; López-Arencibia A; Campillo NE; Piñero JE; Lorenzo-Morales J; Gil C
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malabaricones from the fruit of Myristica cinnamomea King as potential agents against Acanthamoeba castellanii.
    Ahmed U; Sivasothy Y; Khan KM; Khan NA; Wahab SMA; Awang K; Othman MA; Anwar A
    Acta Trop; 2023 Dec; 248():107033. PubMed ID: 37783284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (‒)-Epicatechin reveals amoebicidal activity against Acanthamoeba castellanii by activating the programmed cell death pathway.
    Lê HG; Kang JM; Võ TC; Yoo WG; Hong Y; Na BK
    Phytomedicine; 2024 Mar; 125():155389. PubMed ID: 38306720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
    Kulsoom H; Baig AM; Siddiqui R; Khan NA
    Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii.
    Shahbaz MS; Anwar A; Saad SM; Kanwal ; Anwar A; Khan KM; Siddiqui R; Khan NA
    Parasitol Res; 2020 Jul; 119(7):2327-2335. PubMed ID: 32476058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.
    Deng Y; Ran W; Man S; Li X; Gao H; Tang W; Tachibana H; Cheng X
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4680-8. PubMed ID: 26014935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.
    Taravaud A; Loiseau PM; Pomel S
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):328-336. PubMed ID: 28918001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactase can target cellular differentiation of Acanthamoeba castellanii belonging to the T4 genotype.
    Simau FA; Ahmed U; Khan KM; Khan NA; Siddiqui R; Alharbi AM; Alfahemi H; Anwar A
    Parasitol Res; 2024 Jan; 123(2):117. PubMed ID: 38294565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
    Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
    Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
    Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
    Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobenzofuran-1(3H)-one derivatives: Amoebicidal activity and program cell death in Acanthamoeba castellanii Neff.
    Rodríguez-Expósito RL; Reyes-Batlle M; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
    Biomed Pharmacother; 2022 Jun; 150():113062. PubMed ID: 35658232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
    Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
    Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methanolic extract of Peganum harmala exhibit potent activity against Acanthamoeba castellanii cysts and its encystment in vitro.
    Shohaib HM; Nawaz S; Matin A
    Pak J Pharm Sci; 2016 Nov; 29(6):1993-1996. PubMed ID: 28375115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
    Sharma G; Kalra SK; Tejan N; Ghoshal U
    Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of medicinal chemistry for drug discovery against Acanthamoeba infections.
    Ahmed U; Anwar A; Ong SK; Anwar A; Khan NA
    Med Res Rev; 2022 Jan; 42(1):462-512. PubMed ID: 34472107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
    Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
    Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
    Debnath A; Tunac JB; Silva-Olivares A; Galindo-Gómez S; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2014; 58(3):1523-8. PubMed ID: 24366747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
    Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
    Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
    Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.